EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection

Vasu Nandhakumar iD, Latchumanadhas Kalidoss, Janakiraman Ezhilan, Shahina Begam, Mullasari S Ajit iD

Circulation: Cardiovascular Interventions · 2024

DOI: 10.1161/circinterventions.124.014044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2024. Verfasst von Vasu Nandhakumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Institute of Cardio-Vascular Diseases, The Madras Medical Mission Hospital, Chennai, India. Hauptthemen laut MEDLINE: Mitral Valve, Intracranial Embolism, Cardiac Catheterization, Heart Valve Prosthesis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Surgery or fibrinolysis is the currently available evidence-based treatment for obstructive mechanical valve thrombus. We reported the feasibility and short-term outcomes of percutaneous transcatheter therapy with cerebral embolic protection. Mid- and long-term outcomes remain unknown. METHODS: From 2020 to 2023, 24 patients underwent percutaneous transcatheter release of stuck leaflets with cerebral embolic protection for obstructive mitral mechanical valve thrombus. The indications for the transcatheter therapy were failed fibrinolysis, contraindications for fibrinolysis, not willing for fibrinolysis, or high risk for surgery. The study participants were followed up for a median period of 344.50 (65.00–953.75) days. RESULTS: Technical success was achieved in 91.67% (n=22) of procedures. During the follow-up, 12.50% (n=3) all-cause death, 4.17% (n=1) stroke, and 16.67% (n=4) recurrence were seen. The mean survival time free from death was 1101.48 (95% CI, 929.49–1273.47) days, stroke was 1211.38 (95% CI, 1110.40–1312.35) days, and recurrence was 907.71 (95% CI, 760.20–1055.21) days. CONCLUSIONS: Transcatheter release of the stuck mitral mechanical valve with cerebral embolic protection is an alternative therapy with promising mid-term outcomes where surgery or fibrinolysis is not possible or in failed fibrinolysis subsets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral ValveIntracranial EmbolismCardiac CatheterizationHeart Valve ProsthesisHeart Valve Prosthesis ImplantationEmbolic Protection DevicesHumansMaleFemaleAgedMiddle AgedTime FactorsRisk FactorsTreatment OutcomeRetrospective StudiesAged, 80 and overRecurrenceProsthesis DesignThrombosisFeasibility StudiesProsthesis FailureRisk Assessment

Stichwörter der Autor:innen

balloon valvuloplastycardiac valve prosthesisembolic protection devicesmitral valvethrombolytic therapythrombus

Autor:innen und Institutionen

  • Department of Cardiology, Institute of Cardio-Vascular Diseases, The Madras Medical Mission Hospital, Chennai, India.

ORCID-Profile: Vasu Nandhakumar, Mullasari S Ajit

Zitieren

APA

Nandhakumar, V., Kalidoss, L., Ezhilan, J., Begam, S., & Ajit, M. S. (2024). Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.124.014044

Vancouver

Nandhakumar V, Kalidoss L, Ezhilan J, Begam S, Ajit MS. Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection. Circulation: Cardiovascular Interventions. 2024. doi:10.1161/circinterventions.124.014044

BibTeX
@article{Nandhakumar2024,
  author = {Nandhakumar, Vasu and Kalidoss, Latchumanadhas and Ezhilan, Janakiraman and Begam, Shahina and Ajit, Mullasari S},
  title = {Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2024},
  doi = {10.1161/circinterventions.124.014044}
}
Kostenlos starten →